---
{"dg-publish":true,"permalink":"/USMLE/MSK/Vitiligo/"}
---

# Epidemiology
---
Peak incidence: 10–30 years

# Etiology
---
- <span style="background:rgba(240, 200, 0, 0.2)">Vitiligo is characterized by an absence of melanocytes in the depigmented lesions.</span>
	- Maybe due to autoimmune destruction of melanocytes

# Pathophysiology
---


# Clinical features
---
![L7376.jpg](/img/user/appendix/L7376.jpg)
- <span style="background:rgba(240, 200, 0, 0.2)">Irregular, well-demarcated, depigmented (white) macules or patches</span>
- Unilateral or bilateral distribution, with stable or slowly progressive lesions
- <span style="background:rgba(240, 200, 0, 0.2)">Leukotrichia: depigmented hair</span>; an indicator of poor prognosis 
- <span style="background:rgba(240, 200, 0, 0.2)">Coexisting autoimmune diseases (∼ 20% of patients) </span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Most common: [[USMLE/Endocrine/Hashimoto thyroiditis\|Hashimoto thyroiditis]], [[USMLE/Endocrine/Graves disease\|Graves disease]]</span>
	- Other disorders: [[USMLE/Endocrine/Diabetes mellitus\|type 1 diabetes]], [[USMLE/MSK/Psoriasis\|psoriasis]], inflammatory bowel disease, [[USMLE/MSK/Alopecia\|alopecia]] areata, pernicious anemia, Addison disease

# Diagnostics
---
- Differential diagnostics: see [[USMLE/Biochemistry/Catecholamine Synthesis#Albinism\|Catecholamine Synthesis#Albinism]]

# Treatment
---

